Oklahoma City, OK – January 13, 2017 – Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, today announced the addition of Mike O’Mara as Sr. Vice President of Manufacturing Operations. “As Cytovance continues to grow, an efficient and collaborative manufacturing operation becomes critical to our clients’ success,” said Cytovance […]

OKLAHOMA CITY, OK – November 29, 2016 – Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, today announced the addition of Joyce Johnson as Vice President of Human Resources. Joyce joins Cytovance Biologics, Inc. after 18 years of experience in human resources, most recently serving as the Human Resources Executive

Oklahoma City, OK – September 13, 2016 – Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing organization announces the appointment of Jenny Chen to Chief Financial Officer. Jenny Chen has 20 years of successful experience in global finance operations across manufacturing, aviation, and banking industries in the United States, The Netherlands, and China.  Prior to

Oklahoma City, OK – August 9, 2016 – Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing organization announces the appointment of Dr. Jesse McCool to its Board of Directors Dr. McCool, Ph.D., currently serves as Cytovance’s Sr. Vice President of Research & Development. “Dr. McCool embodies the spirit of community and brings talent, expertise, and